Found: 15
Select item for more details and to access through your institution.
Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis.
- Published in:
- Clinical Proteomics, 2020, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12014-020-09294-7
- By:
- Publication type:
- Article
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
UFLC‐Derived CSF Extracellular Vesicle Origin and Proteome.
- Published in:
- Proteomics, 2018, v. 18, n. 24, p. N.PAG, doi. 10.1002/pmic.201800257
- By:
- Publication type:
- Article
CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 8, p. 1296, doi. 10.1002/acn3.51114
- By:
- Publication type:
- Article
Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 10, p. 5395, doi. 10.1007/s00415-022-11195-8
- By:
- Publication type:
- Article
Amyotrophic lateral sclerosis: the complex path to precision medicine.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 10, p. 2454, doi. 10.1007/s00415-018-8983-8
- By:
- Publication type:
- Article
Nutritional pathway for people with motor neurone disease.
- Published in:
- British Journal of Community Nursing, 2016, v. 21, n. 7, p. 360, doi. 10.12968/bjcn.2016.21.7.360
- By:
- Publication type:
- Article
Network Analysis of the CSF Proteome Characterizes Convergent Pathways of Cellular Dysfunction in ALS.
- Published in:
- Frontiers in Neuroscience, 2021, v. 15, p. N.PAG, doi. 10.3389/fnins.2021.642324
- By:
- Publication type:
- Article
The cortical neurophysiological signature of amyotrophic lateral sclerosis.
- Published in:
- Brain Communications, 2024, v. 6, n. 3, p. 1, doi. 10.1093/braincomms/fcae164
- By:
- Publication type:
- Article
Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosis.
- Published in:
- Brain Communications, 2023, v. 5, n. 4, p. 1, doi. 10.1093/braincomms/fcad211
- By:
- Publication type:
- Article
Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis.
- Published in:
- Brain Communications, 2023, v. 5, n. 3, p. 1, doi. 10.1093/braincomms/fcad163
- By:
- Publication type:
- Article
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain.
- Published in:
- Brain Communications, 2022, v. 4, n. 1, p. 1, doi. 10.1093/braincomms/fcac029
- By:
- Publication type:
- Article
Data‐independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis.
- Published in:
- Journal of Neurochemistry, 2024, v. 168, n. 2, p. 115, doi. 10.1111/jnc.16030
- By:
- Publication type:
- Article
Advantages of routine next‐generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 8, p. 2240, doi. 10.1111/ene.15855
- By:
- Publication type:
- Article